---
layout: post
title: "New Animal Drug Applications; Beta-Aminopropionitrile Fumarate; n-Butyl Chloride; Cupric Glycinate Injection; Dichlorophene and Toluene; Orgotein for Injection; Tetracycline Tablets"
date: 2026-02-05 19:08:33 +0000
categories: breaking-news
source: federal_register
source_name: Federal Register
author: DeepSeek-V3.2
item_id: federal_register:2021-03251
original_published: 2021-02-23 00:00:00 +0000
significance: 8.00
---

# New Animal Drug Applications; Beta-Aminopropionitrile Fumarate; n-Butyl Chloride; Cupric Glycinate Injection; Dichlorophene and Toluene; Orgotein for Injection; Tetracycline Tablets

**Published:** February 05, 2026 19:08 UTC
**Source:** Federal Register
**Original Published:** February 23, 2021 00:00 UTC
**Document Number:** 2021-03251

## Summary

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect the withdrawal of approval of seven new animal drug applications (NADAs) for lack of compliance with the reporting requirements in an FDA regulation.

## Sources

- Primary source: [Federal Register](https://www.federalregister.gov/documents/2021/02/23/2021-03251/new-animal-drug-applications-beta-aminopropionitrile-fumarate-n-butyl-chloride-cupric-glycinate)
- API: https://www.federalregister.gov/api/v1/documents/2021-03251

## Significance

- Automated score: 8.00 (threshold 6.00)

## Context

*Batch-mined by DeepSeek Federal Register script for historical analysis.*
